Ungang, Melbert Cris T.

HRN: 29-46-79  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/12/2026
CEFUROXIME 750MG (VIAL)
08/12/2026
08/18/2026
IVT
635mg
Q8
Dengue Shock Syndrome
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Disseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines